0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

Epidemiology of Oral Contraceptives and Cardiovascular Disease

Lisa Chasan-Taber, ScD; and Meir J. Stampfer, MD
[+] Article and Author Information

From Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts. Acknowledgments: The authors thank Rachel Adams and Stephanie Parker for technical assistance. Grant Support: In part by a consulting agreement with Ortho Pharmaceuticals. Requests for Reprints: Lisa Chasan-Taber, ScD, Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, 420 Arnold House, University of Massachusetts, Amherst, MA 01003. Current Author Addresses: Dr. Chasan-Taber: Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, 420 Arnold House, University of Massachusetts, Amherst, MA 01003.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1998;128(6):467-477. doi:10.7326/0003-4819-128-6-199803150-00008
Text Size: A A A

Purpose: To review the association between combined oral contraceptives and cardiovascular disease, with emphasis on oral contraceptives containing low doses of estrogen (low-dose oral contraceptives).

Data Sources: A systematic search of the MEDLINE database was done for all relevant articles published between 1967 (when low-dose oral contraceptives were introduced in the United States) and June 1997. Textbooks, meeting proceedings, and reference lists were also searched.

Study Selection: All English-language human epidemiology studies of oral contraceptives that used cardiovascular disease as an end point were reviewed. Animal and metabolic studies were reviewed only if they were especially relevant to the mechanism of action of oral contraceptives.

Data Extraction: Descriptive and analytic data from each study were collected.

Data Synthesis: Data were organized by cardiovascular end point, study design, estrogen dose, and type of progestogen. Data on relative and absolute risk are presented to address current prescription guidelines.

Conclusions: The risk for cardiovascular disease is lower with current preparations of oral contraceptives, including those that contain the new progestogens, than with older oral contraceptives containing high doses of estrogen. Among users of low-dose oral contraceptives, cardiovascular diseases occur mainly in smokers and women with predisposing factors. Every effort should be made to encourage smoking cessation among potential users of oral contraceptives.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev 2014;3():CD010813.
Managing menopause. J Obstet Gynaecol Can 2014;36(9):830-3.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)